COVID-19 Myocarditis: A Case Report, Overview of Diagnosis and Treatment.
Infect Dis Clin Pract (Baltim Md)
; 29(6): e414-e417, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1528215
ABSTRACT
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged in Wuhan, China, and rapidly led to a global pandemic that affected 213 countries, more than 5.8 million cases, and 360,000 deaths worldwide as of May 28, 2020. The United States currently has the highest number of COVID-19 cases in the world and contributes to nearly a third of the global death rate. The prevalence of COVID myocarditis is unclear but generally considered rare, with estimates up to 7% of COVID-related deaths. However, these patients suffered catastrophic worsening disease with respiratory compromise requiring intubation and often death. We report the case of a patient with COVID-19-induced myocarditis who was successfully treated with dexamethasone and review the literature.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Observational study
Language:
English
Journal:
Infect Dis Clin Pract (Baltim Md)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS